Andrew Peller (ADW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Q1 revenue was CAD $99.5 million, down 1% year-over-year, with a stable gross margin of 38.4%.
EBITDA/EBITA increased to CAD $12.9 million from CAD $12.7 million, reflecting cost savings and operational efficiencies.
Net loss narrowed to $0.4 million ($0.01 per Class A share) from $0.9 million ($0.02 per share) in the prior year.
The company is navigating a challenging economic environment with elevated interest rates and inflation, but operational results remained consistent year-over-year.
Focus remains on cost savings, operational efficiencies, and building shareholder value, including new product launches and brand growth.
Financial highlights
Q1 sales decreased by CAD $1 million or 1% year-over-year to CAD $99.5 million.
Margin for Q1 was CAD $38.2 million, down 2.2% from the prior year; margin as a percentage of sales was 38.4%, slightly lower than last year's 38.8%.
EBITDA/EBITA increased to CAD $12.9 million from CAD $12.7 million year-over-year.
Selling and administrative expenses were CAD $25.3 million, down 3.8% year-over-year.
Net loss was $0.4 million ($0.01 per Class A share) vs. $0.9 million ($0.02 per share) in Q1 2024.
Outlook and guidance
Cost savings and production efficiency programs are expected to sustain and improve margins long-term.
The company remains focused on market share growth, margin recovery, cash generation, and debt reduction.
Initiatives include new product launches and continued cost optimization.
Anticipates busier second and third quarters, leveraging award-winning estates and brand portfolio.
Anticipates continued adaptation to changing economic and industry conditions.
Latest events from Andrew Peller
- Q3 2026 delivered 3.3% sales growth, record margins, and higher EBITA, with net debt reduced.ADW
Q3 20263 Mar 2026 - Record margins and innovation in health-focused products drive growth and future opportunities.ADW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Margin and EBITDA growth, cost savings, and retail gains drive improved results and outlook.ADW
Q4 20243 Feb 2026 - Revenue and EBITDA rose, but net earnings fell; retail and support programs drove growth.ADW
Q2 202515 Jan 2026 - Q3 2025 net earnings rose to $7.7M on 5.2% revenue growth and margin expansion.ADW
Q3 202524 Dec 2025 - Q1 saw 25% EBITDA growth, margin gains, and debt reduction amid strong domestic wine demand.ADW
Q1 202624 Nov 2025 - Q2 2026 saw margin and earnings growth, offsetting lower revenue and boosting outlook.ADW
Q2 202613 Nov 2025 - Net earnings rebounded to $11.1M on record revenue, margin gains, and lower debt.ADW
Q4 202513 Nov 2025 - Strong asset base, broad distribution, and strategic focus drive sustained profitability.ADW
Investor Presentation2 Jul 2025